The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu

Retrovirology

Volumn 6, Issue , 2009, Pages 80-

  Andrew, Amy J ^a   Miyagi, Eri ^a   Kao, Sandra ^a   Strebel, Klaus ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOHYDRATE; CELL PROTEIN; CONCANAVALIN A; CYSTEINE; DIMER; GLYCOPROTEIN; LECTIN; MANNOSE; PROTEIN BST 2; TETHERIN; UNCLASSIFIED DRUG; VPU PROTEIN; BST2 PROTEIN, HUMAN; DISULFIDE; HUMAN IMMUNODEFICIENCY VIRUS PROTEIN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; VIRUS PROTEIN; VPU PROTEIN, HUMAN IMMUNODEFICIENCY VIRUS 1;

ARTICLE; CELL LINE; CELL SURFACE; CONTROLLED STUDY; DIMERIZATION; FLUORESCENCE ACTIVATED CELL SORTING; GENETIC TRANSFECTION; GLYCOSYLATION; HELA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MUTANT; NONHUMAN; PLASMID; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN MODIFICATION; RODENT; SENSITIVITY ANALYSIS; VIRION; VIRUS INHIBITION; VIRUS PARTICLE; WILD TYPE; AMINO ACID SUBSTITUTION; CELL MEMBRANE; CHEMISTRY; DRUG ANTAGONISM; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; SITE DIRECTED MUTAGENESIS; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; RODENTIA;

AMINO ACID SUBSTITUTION; ANTIGENS, CD; CELL LINE; CELL MEMBRANE; CYSTEINE; DIMERIZATION; DISULFIDES; GLYCOSYLATION; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; MUTAGENESIS, SITE-DIRECTED; VIRAL REGULATORY AND ACCESSORY PROTEINS; VIRUS REPLICATION;

EID: 70349935302     PISSN: None     EISSN: 17424690     Source Type: Journal    
DOI: 10.1186/1742-4690-6-80     Document Type: Article

References (53)

1. Strebel K, Klimkait T, Martin MA. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 1988, 241:1221-1223. 10.1126/science.3261888, 3261888.
2. Cohen EA, Terwilliger EF, Sodroski JG, Haseltine WA. Identification of a protein encoded by the vpu gene of HIV-1. Nature 1988, 334:532-534. 10.1038/334532a0, 3043230.
3. Willey RL, Maldarelli F, Martin MA, Strebel K. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J Virol 1992, 66:7193-7200. 240416, 1433512.
4. Willey RL, Maldarelli F, Martin MA, Strebel K. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J Virol 1992, 66:226-234. 238279, 1727486.
5. Klimkait T, Strebel K, Hoggan MD, Martin MA, Orenstein JM. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J Virol 1990, 64:621-629. 249152, 2404139.
6. Strebel K, Klimkait T, Maldarelli F, Martin MA. Molecular and biochemical analyses of human immunodeficiency virus type 1 vpu protein. J Virol 1989, 63:3784-3791. 250971, 2788224.
7. Terwilliger EF, Cohen EA, Lu YC, Sodroski JG, Haseltine WA. Functional role of human immunodeficiency virus type 1 vpu. Proc Natl Acad Sci USA 1989, 86:5163-5167. 10.1073/pnas.86.13.5163, 297578, 2472639.
8. Friborg J, Ladha A, Gottlinger H, Haseltine WA, Cohen EA. Functional analysis of the phosphorylation sites on the human immunodeficiency virus type 1 Vpu protein. J Acquir Immune Defic Syndr Hum Retrovirol 1995, 8:10-22.
9. Yao XJY, Goettlinger H, Haseltine WA, Cohen EA. Envelope glycoprotein and CD4 independence of Vpu-facilitated human immunodeficiency virus type 1 capsid export. J Virol 1992, 66:5119-5126. 241384, 1629967.
10. Schubert U, Henklein P, Boldyreff B, Wingender E, Strebel K, Porstmann T. The human immunodeficiency virus type 1 encoded Vpu protein is phosphorylated by casein kinase-2 (CK-2) at positions Ser52 and Ser56 within a predicted alpha-helix-turn-alpha-helix-motif. J Mol Biol 1994, 236:16-25. 10.1006/jmbi.1994.1114, 8107101.
11. Geraghty RJ, Panganiban AT. Human immunodeficiency virus type 1 Vpu has a CD4- and an envelope glycoprotein-independent function. J Virol 1993, 67:4190-4194. 237788, 8510220.
12. Schubert U, Bour S, Ferrer-Montiel AV, Montal M, Maldarell F, Strebel K. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J Virol 1996, 70:809-819. 189883, 8551619.
13. Paul M, Mazumder S, Raja N, Jabbar MA. Mutational analysis of the human immunodeficiency virus type 1 Vpu transmembrane domain that promotes the enhanced release of virus-like particles from the plasma membrane of mammalian cells. J Virol 1998, 72:1270-1279. 124605, 9445027.
14. Neil SJ, Eastman SW, Jouvenet N, Bieniasz PD. HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane. PLoS Pathog 2006, 2:e39. 10.1371/journal.ppat.0020039, 1458960,1458960, 16699598.
15. Piller SC, Ewart GD, Premkumar A, Cox GB, Gage PW. Vpr protein of human immunodeficiency virus type 1 forms cation-selective channels in planar lipid bilayers. Proc Natl Acad Sci USA 1996, 93:111-115. 10.1073/pnas.93.1.111, 40188, 8552585.
16. Ewart GD, Sutherland T, Gage PW, Cox GB. The Vpu protein of human immunodeficiency virus type 1 forms cation- selective ion channels. J Virol 1996, 70:7108-7115. 190763, 8794357.
17. Schubert U, Ferrer-Montiel AV, Oblatt-Montal M, Henklein P, Strebel K, Montal M. Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1-infected cells. FEBS Lett 1996, 398:12-18. 10.1016/S0014-5793(96)01146-5, 8946945.
18. Marassi FM, Ma C, Gratkowski H, Straus SK, Strebel K, Oblatt-Montal M, Montal M, Opella SJ. Correlation of the structural and functional domains in the membrane protein Vpu from HIV-1. Proc Natl Acad Sci USA 1999, 96:14336-14341. 10.1073/pnas.96.25.14336, 24437, 10588706.
19. Ma C, Marassi FM, Jones DH, Straus SK, Bour S, Strebel K, Schubert U, Oblatt-Montal M, Montal M, Opella SJ. Expression, purification, and activities of full-length and truncated versions of the integral membrane protein Vpu from HIV-1. Protein Sci 2002, 11:546-557. 10.1110/ps.37302, 2373459, 11847278.
20. Hsu K, Seharaseyon J, Dong P, Bour S, Marban E. Mutual Functional Destruction of HIV-1 Vpu and Host TASK-1 Channel. Mol Cell 2004, 14:259-267. 10.1016/S1097-2765(04)00183-2, 15099524.
21. Varthakavi V, Smith RM, Bour SP, Strebel K, Spearman P. Viral protein U counteracts a human host cell restriction that inhibits HIV-1 particle production. Proc Natl Acad Sci USA 2003, 100:15154-15159. 10.1073/pnas.2433165100, 299932, 14657387.
22. Callahan MA, Handley MA, Lee YH, Talbot KJ, Harper JW, Panganiban AT. Functional interaction of human immunodeficiency virus type 1 Vpu and Gag with a novel member of the tetratricopeptide repeat protein family. J Virol 1998, 72:5189-5197. 110095, 9573291.
23. Van Damme N, Goff D, Katsura C, Jorgenson RL, Mitchell R, Johnson MC, Stephens EB, Guatelli J. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 2008, 3:245-252. 10.1016/j.chom.2008.03.001, 2474773, 18342597.
24. Neil SJ, Zang T, Bieniasz PD. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 2008, 451:425-430. 10.1038/nature06553, 18200009.
25. Varthakavi V, Heimann-Nichols E, Smith RM, Sun Y, Bram RJ, Ali S, Rose J, Ding L, Spearman P. Identification of calcium-modulating cyclophilin ligand as a human host restriction to HIV-1 release overcome by Vpu. Nat Med 2008, 14:641-647. 10.1038/nm1778, 2652483, 18500349.
26. Bartee E, McCormack A, Fruh K. Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. PLoS Pathog 2006, 2:e107. 10.1371/journal.ppat.0020107, 1626102, 17238276.
27. Neil SJ, Sandrin V, Sundquist WI, Bieniasz PD. An interferon-alpha-induced tethering mechanism inhibits HIV-1 and Ebola virus particle release but is counteracted by the HIV-1 Vpu protein. Cell Host Microbe 2007, 2:193-203. 10.1016/j.chom.2007.08.001, 18005734.
28. Goto T, Kennel SJ, Abe M, Takishita M, Kosaka M, Solomon A, Saito S. A novel membrane antigen selectively expressed on terminally differentiated human B cells. Blood 1994, 84:1922-1930.
29. Ohtomo T, Sugamata Y, Ozaki Y, Ono K, Yoshimura Y, Kawai S, Koishihara Y, Ozaki S, Kosaka M, Hirano T, Tsuchiya M. Molecular cloning and characterization of a surface antigen preferentially overexpressed on multiple myeloma cells. Biochem Biophys Res Commun 1999, 258:583-591. 10.1006/bbrc.1999.0683, 10329429.
30. Ishikawa J, Kaisho T, Tomizawa H, Lee BO, Kobune Y, Inazawa J, Oritani K, Itoh M, Ochi T, Ishihara K. Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth. Genomics 1995, 26:527-534. 10.1016/0888-7543(95)80171-H, 7607676.
31. Kupzig S, Korolchuk V, Rollason R, Sugden A, Wilde A, Banting G. Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 2003, 4:694-709. 10.1034/j.1600-0854.2003.00129.x, 12956872.
32. Sakuma T, Noda T, Urata S, Kawaoka Y, Yasuda J. Inhibition of Lassa and Marburg virus production by tetherin. J Virol 2009, 83:2382-2385. 10.1128/JVI.01607-08, 2643706, 19091864.
33. Rong L, Zhang J, Lu J, Pan Q, Lorgeoux RP, Aloysius C, Guo F, Liu SL, Wainberg MA, Liang C. The Transmembrane Domain of BST-2 Determines Its Sensitivity to Down-Modulation by HIV-1 Vpu. J Virol 2009, 83:7536-46. 10.1128/JVI.00620-09, 19474106.
34. McNatt MW, Zang T, Hatziioannou T, Bartlett M, Fofana IB, Johnson WE, Neil SJ, Bieniasz PD. Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog 2009, 5:e1000300. 10.1371/journal.ppat.1000300, 2633611, 19214216.
35. Gupta RK, Hue S, Schaller T, Verschoor E, Pillay D, Towers GJ. Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog 2009, 5:e1000443. 10.1371/journal.ppat.1000443, 2678251, 19461879.
36. Hout DR, Gomez ML, Pacyniak E, Gomez LM, Inbody SH, Mulcahy ER, Culley N, Pinson DM, Powers MF, Wong SW, Stephens EB. Scrambling of the amino acids within the transmembrane domain of Vpu results in a simian-human immunodeficiency virus (SHIV(TM)) that is less pathogenic for pig-tailed macaques. Virology 2005, 339:56-69. 10.1016/j.virol.2005.04.038, 15975620.
37. Miyagi E, Andrew AJ, Kao S, Strebel K. Vpu enhances HIV-1 virus release in the absence of Bst-2 cell surface down-modulation and intracellular depletion. Proc Natl Acad Sci USA 2009, 106:2868-2873. 10.1073/pnas.0813223106, 2650357, 19196977.
38. Mitchell RS, Katsura C, Skasko MA, Fitzpatrick K, Lau D, Ruiz A, Stephens EB, Margottin-Goguet F, Benarous R, Guatelli JC. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog 2009, 5:e1000450. 10.1371/journal.ppat.1000450, 2679223, 19478868.
39. Goffinet C, Allespach I, Homann S, Tervo HM, Habermann A, Rupp D, Oberbremer L, Kern C, Tibroni N, Welsch S, Krijnse-Locker J, Banting G, Krausslich HG, Fackler OT, Keppler OT. HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. Cell Host Microbe 2009, 5:285-297. 10.1016/j.chom.2009.01.009, 19286137.
40. Douglas JL, Viswanathan K, McCarroll MN, Gustin JK, Fruh K, Moses AV. Vpu Directs the Degradation of the HIV Restriction Factor BST-2/tetherin via a {beta}TrCP-dependent Mechanism. J Virol 2009, 83:7931-47. 10.1128/JVI.00242-09, 19515779.
41. Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986, 59:284-291. 253077, 3016298.
42. Nguyen KL, llano M, Akari H, Miyagi E, Poeschla EM, Strebel K, Bour S. Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression. Virology 2004, 319:163-175. 10.1016/j.virol.2003.11.021, 15015498.
43. Maldarelli F, Chen MY, Willey RL, Strebel K. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J Virol 1993, 67:5056-5061. 237897, 8331740.
44. Carlsson SR, Fukuda M. The polylactosaminoglycans of human lysosomal membrane glycoproteins lamp-1 and lamp-2. Localization on the peptide backbones. J Biol Chem 1990, 265:20488-20495.
45. Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Annu Rev Biochem 1985, 54:631-664. 10.1146/annurev.bi.54.070185.003215, 3896128.
46. Maley F, Trimble RB, Tarentino AL, Plummer TH. Characterization of glycoproteins and their associated oligosaccharides through the use of endoglycosidases. Anal Biochem 1989, 180:195-204. 10.1016/0003-2697(89)90115-2, 2510544.
47. Tsay GC, Dawson G, Li YT. Structure of the glycopeptide storage material in GM 1 gangliosidosis. Sequence determination with specific endo- and exoglycosidases. Biochim Biophys Acta 1975, 385:305-311.
48. Ogura H, Matsunaga I, Takano Y, Ning X, Ayata M, Tanaka K, Seto T, Furukawa K, Ito N, Shingai M, Kimura T, Ichihara K, Kubo H, Murakami T. Cell surface expression of immature H glycoprotein in measles virus-infected cells. Virus Res 2000, 66:187-196. 10.1016/S0168-1702(00)00124-6, 10725551.
49. Shiraishi N, Yoshima H, Maeda S, Mizoguchi A, Matsumoto A, Sugiyama T, Kobata A. Cell surface glycoprotein and asparagine-linked sugar chain patterns of rat erythroleukemic cell lines. Cancer Res 1982, 42:2884-2893.
50. Kaletsky RL, Francica JR, Agrawal-Gamse C, Bates P. Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. Proc Natl Acad Sci USA 2009, 106:2886-2891. 10.1073/pnas.0811014106, 2650360, 19179289.
51. Schubert U, Strebel K. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J Virol 1994, 68:2260-2271. 236702, 8139011.
52. Dube M, Roy BB, Guiot-Guillain P, Mercier J, Binette J, Leung G, Cohen EA. Suppression of Tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J Virol 2009, 83:4574-4590. 10.1128/JVI.01800-08, 19244337.
53. Bour S, Perrin C, Strebel K. Cell surface CD4 inhibits HIV-1 particle release by interfering with Vpu activity. J Biol Chem 1999, 274:33800-33806. 10.1074/jbc.274.47.33800, 10559275.